TY - JOUR
T1 - Mitochondrial function in the heart: the insight into mechanisms and therapeutic potentials.
AU - Nguyen, Binh
AU - Ruiz Velasco Hernandez, Andrea
AU - Bui, Thuy
AU - Collins, Lucy
A2 - Wang, Xin
A2 - Liu, Wei
PY - 2018/7/2
Y1 - 2018/7/2
N2 - Mitochondrial dysfunction is considered as a crucial contributory factor in cardiac pathology. This has highlighted the therapeutic potential of targeting mitochondria to prevent or treat cardiac disease. Mitochondrial dysfunction is associated with aberrant electron transport chain activity, reduced ATP production, an abnormal shift in metabolic substrates, ROS overproduction and impaired mitochondrial dynamics. This review will cover the mitochondrial functions and how they are altered in various disease conditions. Furthermore, the mechanisms that lead to mitochondrial defects and the protective mechanisms that prevent mitochondrial damage will be discussed. Finally, potential mitochondrial targets for novel therapeutic intervention will be explored. We will highlight the development of small molecules that target mitochondria from different perspectives and their current progress in clinical trials.
AB - Mitochondrial dysfunction is considered as a crucial contributory factor in cardiac pathology. This has highlighted the therapeutic potential of targeting mitochondria to prevent or treat cardiac disease. Mitochondrial dysfunction is associated with aberrant electron transport chain activity, reduced ATP production, an abnormal shift in metabolic substrates, ROS overproduction and impaired mitochondrial dynamics. This review will cover the mitochondrial functions and how they are altered in various disease conditions. Furthermore, the mechanisms that lead to mitochondrial defects and the protective mechanisms that prevent mitochondrial damage will be discussed. Finally, potential mitochondrial targets for novel therapeutic intervention will be explored. We will highlight the development of small molecules that target mitochondria from different perspectives and their current progress in clinical trials.
UR - http://www.scopus.com/inward/record.url?scp=85053212722&partnerID=8YFLogxK
U2 - 10.1111/bph.14431
DO - 10.1111/bph.14431
M3 - Article
SN - 0007-1188
JO - British Journal of Pharmacology
JF - British Journal of Pharmacology
ER -